Impedimed Limited (ASX:IPD)’s stock price fell 7.3% during trading on Tuesday . The stock traded as low as A$0.19 ($0.13) and last traded at A$0.19 ($0.13), 1,705,107 shares traded hands during mid-day trading. The stock had previously closed at A$0.21 ($0.15).

The company has a market capitalization of $96.38 million and a PE ratio of -2.97. The firm’s fifty day simple moving average is A$0.16 and its 200 day simple moving average is A$0.16.

Impedimed Company Profile (ASX:IPD)

ImpediMed Limited, together with its subsidiaries, develops, manufactures, and sells bioimpedance instruments, consumables, and software in Australia, North America, and internationally. The company operates through Medical and Test & Measurement segments. It offers SOZO, a next generation bioimpedance spectroscopy digital health platform; and L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb.

See Also: What are the benefits of investing in REITs?

Receive News & Ratings for Impedimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Impedimed and related companies with MarketBeat.com's FREE daily email newsletter.